![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Krzysztof Nosek, Wojciech Leppert, Hanna Nosek, Jerzy Wordliczek & Dariusz Onichimowski. (2017) A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients. Drug Design, Development and Therapy 11, pages 2409-2419.
Read now
Read now
Wojciech Leppert & Grzegorz Kowalski. (2015) Long-term administration of high doses of transdermal buprenorphine in cancer patients with severe neuropathic pain. OncoTargets and Therapy 8, pages 3621-3627.
Read now
Read now
Kate Miller, Aaron Yarlas, Warren Wen, Bradley Dain, Shau Yu Lynch, Michael J Brennan & Steven R Ripa. (2013) Buprenorphine transdermal system and quality of life in opioid-experienced patients with chronic low back pain. Expert Opinion on Pharmacotherapy 14:3, pages 269-277.
Read now
Read now
Tommaso Setti, Filippo Sanfilippo & Yigal Leykin. (2012) Transdermal buprenorphine for postoperative pain control in gynecological surgery: a prospective randomized study. Current Medical Research and Opinion 28:10, pages 1597-1608.
Read now
Read now
Sheila M. Seed, Kaelen C. Dunican, Ann M. Lynch & Alicia R. Desilets. (2012) An Update in Options for the Treatment of Pain: A Review of New Opioid Formulations. Hospital Practice 40:1, pages 166-175.
Read now
Read now
Articles from other publishers (18)
Tai‐Lin Huang, Yen‐Min Huang, Min‐Mo Hou, Chang‐Hsien Lu, Tsu‐Yi Chao, Tai‐Jan Chiu, Yueh‐Shih Chang, Sheng‐Hao Lin, Ching‐Hsiung Lin, Yen‐Hao Chen, Cheng‐Hsu Wang, Jen‐Shi Chen & Wen‐Chi Shen. (2022) Safety and effectiveness of transdermal buprenorphine in cancer pain: An observational study in Taiwan (SOOTHE). Asia-Pacific Journal of Clinical Oncology 19:2.
Crossref
Crossref
. 2022. Arzneimitteltherapie in der Palliativmedizin. Arzneimitteltherapie in der Palliativmedizin
511
774
.
Joanna Bogacka, Katarzyna Ciapała, Katarzyna Pawlik, Jan Dobrogowski, Anna Przeklasa-Muszynska & Joanna Mika. (2020) Blockade of CCR4 Diminishes Hypersensitivity and Enhances Opioid Analgesia – Evidence from a Mouse Model of Diabetic Neuropathy. Neuroscience 441, pages 77-92.
Crossref
Crossref
Yuki Sumazaki Watanabe, Tomofumi Miura, Ayumi Okizaki, Keita Tagami, Yoshihisa Matsumoto, Maiko Fujimori, Tatsuya Morita & Hiroya Kinoshita. (2018) Comparison of Indicators for Achievement of Pain Control With a Personalized Pain Goal in a Comprehensive Cancer Center. Journal of Pain and Symptom Management 55:4, pages 1159-1164.
Crossref
Crossref
. 2018. Arzneimitteltherapie in der Palliativmedizin. Arzneimitteltherapie in der Palliativmedizin
447
696
.
Jeannine Brant, Lisa Keller, Karen McLeod, Chao Hsing Yeh & Linda Eaton. (2017) Chronic and Refractory Pain: A Systematic Review of Pharmacologic Management in Oncology
. Clinical Journal of Oncology Nursing 21:3, pages 31-59.
Crossref
Crossref
Timothy J. Wiegand, Marie-Claire Le Lait, Becki Bucher Bartelson, Richard C. Dart & Jody L. Green. (2016) Analysis of the Abuse and Diversion of the Buprenorphine Transdermal Delivery System. The Journal of Pain 17:6, pages 745-752.
Crossref
Crossref
Joseph V Pergolizzi. (2016) Analgesia for Moderate Chronic Non-Cancer Pain : Low Dose Transdermal Buprenorphine A Novel Option in Mexico. Journal of Anesthesia and Surgery 3:3, pages 1-6.
Crossref
Crossref
Eric Prommer. (2014) Buprenorphine for Cancer Pain. American Journal of Hospice and Palliative Medicine® 32:8, pages 881-889.
Crossref
Crossref
. 2015. Arzneimitteltherapie in der Palliativmedizin. Arzneimitteltherapie in der Palliativmedizin
417
651
.
Gerardo Correa-Illanes, Ricardo G Roa, José Luis B Piñeros, Flavia T Ferrer & Victoria R Adriasola. (2014)
Retrospective analysis of 4 years of clinical experience with transdermal buprenorphine (Transtec
®
) in post-traumatic pain
. Pain Management 4:3, pages 181-190.
Crossref
Crossref
Wojciech Leppert. (2013) A successful Switch From Transdermal Fentanyl to Transdermal Buprenorphine in a Patient with Neuropathic Pain. American Journal of Hospice and Palliative Medicine® 31:1, pages 101-104.
Crossref
Crossref
Bethany Foster, Robert Twycross, Mary Mihalyo & Andrew Wilcock. (2013) Buprenorphine. Journal of Pain and Symptom Management 45:5, pages 939-949.
Crossref
Crossref
Clifford Gevirtz. (2013) Transdermal Buprenorphine for Chronic Pain Management. Topics in Pain Management 28:6, pages 1-6.
Crossref
Crossref
Stephen M. Husbands. 2013. Research and Development of Opioid-Related Ligands. Research and Development of Opioid-Related Ligands
127
144
.
Guy H. Hans. 2013. Research and Development of Opioid-Related Ligands. Research and Development of Opioid-Related Ligands
103
123
.
Mellar P. Davis. (2012) Twelve Reasons for Considering Buprenorphine as a Frontline Analgesic in the Management of Pain. The Journal of Supportive Oncology 10:6, pages 209-219.
Crossref
Crossref
Dana Vondráčková. (2012) Transdermal buprenorphine in clinical practice: a multicenter, noninterventional postmarketing study in the Czech Republic. Pain Management 2:2, pages 163-168.
Crossref
Crossref